Kelly Jason R
Kelly Jason R, SR, reported a transaction classified as exercise at Ginkgo Bioworks Holdings, Inc. involving 55694.000000 shares. Reported holdings after the transaction were 18564.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 16, 2026
- Filing date
- Oct 21, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingDNA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001628280-26-066703 Restricted Stock Units
- Transaction date
- Oct 16, 2026 Filed Oct 21, 2026, 08:05 PM · 5d delay
- Shares
- 55,694 sh Price unknown
- Estimated value
- — Computed from shares × price
- Holdings after
- 18,564 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-18 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - missing_price-8 points
price_cents is null
Missing price reduces confidence in value-based signals.
- price_cents
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See remarks
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2
Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obl…
- F3
The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.
- F4
The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.
0 other transactions
0 recent txs